Literature DB >> 18423282

Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis.

Nathan C Dewsnup1, Srinivas M Susarla, Mailikai Abulikemu, William C Faquin, Leonard B Kaban, Meredith August.   

Abstract

PURPOSE: To compare CD34 expression in both aggressive and nonaggressive giant cell lesions of the jaws and identify any associations between tumor vascular density and biologic behavior.
MATERIALS AND METHODS: This was a retrospective study of subjects treated for giant cell lesions of the jaws at Massachusetts General Hospital from 1992 to 2006. The primary predictor variable was tumor classification (aggressive or nonaggressive); tumors were considered aggressive if they were greater than 5 cm in size, recurred after treatment, or exhibited 3 of the following: presence of root resorption, tooth displacement, or cortical bone thinning or perforation. Secondary predictor variables, recorded for each patient, were demographic, anatomic, and clinical measures. The outcome variable was the average CD34 staining density of histologic specimens quantified in 2 different areas. Descriptive and bivariate statistics were computed to identify predictors associated with vascular density.
RESULTS: The study sample was composed of 32 subjects with a mean age of 24.4 +/- 19.77 years (range: 2-83); 23 subjects (71.8%) were female. Of the tumors included, 11 (34.4%) were located in the maxilla, 21 (65.6%) in the mandible. Twenty-six tumors (81.2%) were classified as aggressive; the remainder (18.8%) were nonaggressive. There were no statistically significant differences between subjects with aggressive versus nonaggressive tumors with regard to age, gender, or location. Subjects with aggressive tumors had a significantly higher CD34 staining density (P = .02). None of the secondary predictors was associated with vascular density.
CONCLUSION: Vascular density of giant cell tumors of the jaws is significantly increased in aggressive tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423282     DOI: 10.1016/j.joms.2008.01.033

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  5 in total

1.  Treatment Challenges with Benign Bone Tumors of the Orbit.

Authors:  Helen Merritt; Vivian T Yin; Margaret L Pfeiffer; Wei-Lien Wang; Matthew C Sniegowski; Bita Esmaeli
Journal:  Ocul Oncol Pathol       Date:  2015-02-10

2.  Giant cell tumor of the mandible.

Authors:  Se Ra Park; Sa Myung Chung; Jae-Yol Lim; Eun Chang Choi
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-02-23       Impact factor: 3.372

Review 3.  Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases.

Authors:  J E O'Connell; G J Kearns
Journal:  Ir J Med Sci       Date:  2012-10-26       Impact factor: 1.568

4.  FASN expression, angiogenesis and lymphangiogenesis in central and peripheral giant cell lesions.

Authors:  Saulo Gabriel Moreira Falci; Ana Terezinha Marques Mesquita; Bruno Augusto Benevenuto de Andrade; Joao Luiz de Miranda; Jorge Esquiche Leon; Oslei Paes de Almeida; Cassio Roberto Rocha dos Santos
Journal:  J Appl Oral Sci       Date:  2014-04       Impact factor: 2.698

5.  Expression of CD34 and CD31 in Central and Peripheral Giant Cell Granulomas.

Authors:  Donia Sadri; Fatemeh Shahsavari; Maliheh Hezarkhani; Maryam Shafizadeh
Journal:  J Dent (Shiraz)       Date:  2019-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.